GoldenGolden
Indee Labs

Indee Labs

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Edit ID  8717633 

Ryan Pawell
Ryan Pawell edited on 7 Nov, 2018
Edits made to:
Article (+3/-3 characters)
Article

As of May 2018, Indee Labs had accumulated more than USD$5.66.1 million dollars in angel, venture and non-dilutive capital.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.